1.0Impact Factor
2.3CiteScore
21 daysTime to First Decision

COVID, Volume 3, Issue 5

May 2023 - 12 articles

Cover Story: In the context of new therapeutic protocols and vaccines developed in the past three years, coronavirus disease 2019 (COVID-19) continues to exert an important impact on the healthcare systems worldwide. Previous studies have reported heterogenous cardiovascular manifestations in patients with COVID-19, of which are related to the acute episode or even to the potential long-term effect of the viral infection. Recognizing the cardiac implications of COVID-19 extends beyond the acute phase or hospitalization, as they can also significantly affect patients' quality of life and pose a prolonged burden on the healthcare systems in the long term. View this paper

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (12)

Select all

Brief Report

2,353 Views

7 Pages

Evusheld Prophylaxis Improves Social Interactions, Anxiety, Depression, Agoraphobia, and Quality of Life in Blood Cancer Patients

Annabel M. Follows,
Charlotte Clark,
Catherine Dye,
Lorraine King,
Gail Skillings,
Grace Byrne,
Vicki Tinkler and
George A. Follows

COVID2023, 3(5), 664-670;https://doi.org/10.3390/covid3050048

24 April 2023

Evusheld is a combination injection of tixagevimab and cilgavimab and is indicated for the pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older. Its use has been advocated for immunosuppressed individuals, such as bl...

Full Article

Communication

2,458 Views

9 Pages

Genetic Analysis and Epitope Prediction of SARS-CoV-2 Genome in Bahia, Brazil: An In Silico Analysis of First and Second Wave Genomics Diversity

Gabriela Andrade,
Guilherme Matias,
Lara Chrisóstomo,
João da Costa-Neto,
Juan Sampaio,
Arthur Silva and
Isaac Cansanção

COVID2023, 3(5), 655-663;https://doi.org/10.3390/covid3050047

23 April 2023

COVID-19 is an infectious disease caused by SARS-CoV-2. This virus presents high levels of mutation and transmissibility, which contributed to the emergence of the pandemic. Our study aimed to analyze, in silico, the genomic diversity of SARS-CoV-2 s...

Full Article

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

COVID - ISSN 2673-8112

Imprint

Download Flyer